Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria ...

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

Tylah Tully looks at Vertex Minerals and the increasingly alluring gold grades coming out of its Reward gold mine in New ...

Keith Speights has positions in Amazon, Enbridge, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Vertex Minerals Ltd. ( ($AU:VTX) ) has issued an update. Vertex Minerals Ltd. has announced significant progress in its operations at the Reward ...

Vertex Resource Group Ltd. (“Vertex” or the “Company”) reports its financial and operational results for the third quarter ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Savara advances BLA plans with strong molgramostim data, large aPAP market potential, and a reinforced cash position. Find ...

V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 ...

Shraddha Kapoor’s jewellery brand Palmonas is in discussions to raise Rs 200-250 crore from mid-market private equity firm ...

Attentive.ai has raised fresh rounds in its Series B funding round led by Insight Partners, with participation from Vertex ...